|
 |
SelegilineThis page contains recent news articles, when available, and an overview of Selegiline but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Selegiline (when available) Dopamine is an essential chemical that occurs in many parts of the body. It is the premature degradation of dopamine that results in the symptoms of Parkinson's disease. Monoamine oxidase (MAO) is an enzyme which accelerates the breakdown of dopamine. Selegiline can prolong the effects of dopamine in the brain by preventing its breakdown through seletively blocking MAO. It also may prevent the removal of dopamine between nerve endings and enhance release of dopamine from nerve cells. For the adjunct treatment for Parkinson's Disease Mechanism Of Action: Although the mechanisms for selegiline's beneficial action in the treatment of Parkinson's disease are not fully understood, the inhibition of monoamine oxidase type B (MAO B) is thought to be of primary importance. MAO B is involved in the oxidative deamination of dopamine in the brain. Selegiline is best known as an irreversible inhibitor of MAO. MAO's activity is inhibited when selegiline binds to the isoalloxazine flavin adenine dinucleotide (FAD) at its active center. In addition, there is evidence that selegiline may increase dopaminergic activity through other mechanisms. News Articles on Selegiline Successful 2009 for Syntropharma - Dec 18, 2009 The Company raised its first private equity investment October 2006 in order to develop transdermal versions of two CNS drugs: selegiline, for the treatment ... PharmaLive.com (press release) FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing ... - Dec 15, 2009 TSFs of various doses of rasagiline were comparable to those of selegiline and placebo. AZILECT® (rasagiline tablets) is indicated for the treatment of the ... Medical News Today (press release) Four Pharmaceutical Companies Pay $124 Million for Submission of False Claims ... - Oct 19, 2009 Ibuprofen tablets, Bumetanide, Cephalexin and Cefactor) and several UDL drugs (nifedipine extended release tablets, selegiline HCL, Triamterene & HCTZ, ... Reuters New systematic study for managing treatment-resistant bipolar depression - Oct 27, 2009 After 7 weeks of treatment with the selegiline patch 6 mg, her QIDS-SR score was 20 (severe range). Selegiline was discontinued. She was then restarted on ... News-Medical.net Phentermine para adelgazar, contraindicaciones - Nov 10, 2009 Las personas que tomen inhibidores de la MAO como isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), ... Nutricion.pro FDA Clears Antidepression Patch - Feb 28, 2006 Emsam contains selegiline, which is used in tablet form as a treatment for ... Because selegiline can cause many side effects, especially when taken with ... TheStreet.com - TheStreet.com (subscription) Selegiline (Systemic). - Oct 27, 2005 Selegiline ( seh-LEDGE-ah-leen) is used in combination with levodopa or levodopa and carbidopa combination to treat Parkinson's disease, sometimes called ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Selegiline for Parkinson's disease - Dec 8, 2008 Monoamine oxidase inhibitors (MAOIs) prolong the effects of dopamine in the brain by preventing its breakdown. They also may prevent the removal of dopamine ... WebMD Learn about Selegiline Transdermal from Consumer Reports Health. - Jan 8, 2007 A small number of children, teenagers, and young adults (up to 24 years of age) who took ... Full Alert. Transdermal selegiline is used to treat depression. ... consumerreports.org Valeant Parkinson's Drug Cleared - Jun 15, 2006 Zelapar is a version of selegiline, a compound used in treating depression and Parkinson's. In May, Teva Pharmaceutical Industries (TEVA Quote) received FDA ... TheStreet.com - TheStreet.com (subscription) Selegiline transdermal patch (Emsam) for major depressive disorder.( … - Feb 15, 2008 Unlike oral MAO inhibitors, transdermal selegiline delivers ... Transdermal selegiline is contraindicated in patients taking selective serotonin reuptake ... Free with registration - American Family Physician - AccessMyLibrary.com First anti-depressant patch is approved - Mar 2, 2006 The patch contains a medication called Emsam (selegiline), which can trigger sudden spikes in blood pressure if taken orally with certain foods or drinks, ... New Scientist How to take Selegiline Transdermal from Consumer Reports Health. - Jan 8, 2007 A small number of children, teenagers, and young adults (up to 24 years of age) who took ... Full Alert. tell your doctor and pharmacist if you are allergic ... consumerreports.org Dodgy doctor prescribes breast cancer drugs to men - Jul 3, 2008 Selegiline is said to have anti-aging properties, while Anastrozole is sought after by athletes and body builders for its ability to boost testosterone, ... Brisbane Times Fast-dissolving Selegiline (Zelapar Zydis) Reduces "Off-Time" in Up... - Oct 3, 2005 By Paula Moyer. SAN DIEGO, CA -- October 3, 2005 -- The buccally absorbed formulation of selegiline (Zelapar(R)) using the Zydis(R) fast-dissolving ... DG News Learn about Selegiline from Consumer Reports Health. - Jan 7, 2007 Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the ... consumerreports.org FDA Approves EMSAM(R) (selegiline Transdermal System), The First … - Mar 6, 2006 Bristol-Myers Squibb Company (NYSE: BMY) and Somerset Pharmaceuticals, Inc., a joint venture between Mylan Laboratories Inc. (NYSE: MYL) and Watson ... Medical News Today - Medical News Today (press release) How to take Selegiline from Consumer Reports Health. - Jan 7, 2007 Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the ... consumerreports.org … Announces Revised FDA PDUFA Date for EMSAM(R) (Selegiline … - Nov 21, 2005 On October 26, 2005 the Psychopharmacologic Drug Advisory Committee voted EMSAM(R) (selegiline transdermal system) could be safely administered without ... $4.95 - PR Newswire - ECNext SELEGILINE (Oral route) - se-LE-ji-leen.(Drug overview) - May 1, 2007 Selegiline is used in combination with levodopa or levodopa and carbidopa combination to treat Parkinson's disease, sometimes called shaking palsy or ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Disease; Rasagiline, in doses equivalent to selegiline, is less... - Jan 1, 2005 Scientists writing in the British Journal of Pharmacology report, "Selegiline is used for treating Parkinson disease. Despite its efficacy, the clinical use ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … to treat major depressive disorder in adults: once daily EMSAM... - May 1, 2006 EMSAM (selegiline) is the first FDA-approved transdermal patch to treat major ... According to results from several controlled trials, the selegiline ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com … resistant depression, try transdermal selegiline.(Adult Psychiatry)... - Mar 1, 2007 For resistant depression, try transdermal selegiline.(Adult Psychiatry)(Drug overview) ... find Clinical Psychiatry News articles. Pay-Per-View - Clinical Psychiatry News - HighBeam Research STEPS - February 15, 2008 -- American Family Physician - Feb 15, 2008 The selegiline transdermal patch (Emsam) delivers higher, more sustained blood levels to the ... Unlike oral MAO inhibitors, transdermal selegiline delivers ... AAFP News Now Taking Selegiline from Consumer Reports Health. - Jan 7, 2007 Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the ... consumerreports.org Article: Selegiline serves as effective adjunct for PD symptoms.( … - May 1, 2006 WASHINGTON -- An orally disintegrating formulation of selegiline appears to be a safe and effective adjunct for patients with Parkinson's disease who are ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: FDA panel backs selegiline patch for depression.( Food and... - Dec 1, 2005 FDA panel backs selegiline patch for depression.( Food and Drug Administration) ... find Clinical Psychiatry News articles. GAITHERSBURG, MD. Pay-Per-View - Clinical Psychiatry News - HighBeam Research Article: Selegiline reduces some adverse events in Parkinson's.( … - Oct 1, 2008 CHICAGO -- In a group of patients with motor fluctuations and dopamine agonist-related side effects, adding orally disintegrating selegiline and decreasing ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy - Oct 5, 2007 Selegiline, while being predominantly an MAO-B inhibitor (at doses 10 ... Because selegiline is non-selective for MAO subtypes at these higher doses, ... Nature.com First skin patch for depression - Mar 8, 2006 The Food and Drug Administration approved the selegiline transdermal patch, ... Selegiline, approved in pill form by the FDA in 1989 to help treat ... Times Herald-Record selegiline Valeant approvable, USA (Parkinson disease).(Valeant … - Oct 17, 2005 Valeant announced on 4 October 2005 that it has received a second approvable letter from the US FDA, requesting additional clarification on issues ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Press Release: FDA approves emsam (selegiline) as first drug patch... - Mar 1, 2006 FDA approves emsam (selegiline) as first drug patch for depression lowest dose can be used without restrictions required of MAOI class of depression drugs. Pay-Per-View - M2 Presswire - HighBeam Research Business Update; Somerset files response to US FDA letter on selegilin... - Jul 11, 2005 ...to the United States Food and Drug Administration's (FDA) action letter, dated January 30, 2004, related to EMSAM (selegiline transdermal system). ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones … Administration Approves EMSAM(R) (selegiline transdermal system),... - Feb 28, 2006 US Food and Drug Administration Approves EMSAM(R) (selegiline transdermal system), the First Transdermal Patch for the Treatment of Major Depressive ... Pay-Per-View - PR Newswire - HighBeam Research Business Update; Somerset files response to US FDA letter on selegilin... - Jul 12, 2005 ...to the United States Food and Drug Administration's (FDA) action letter, dated January 30, 2004, related to EMSAM (selegiline transdermal system). ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Article: Selegiline safe, effective as adjunct for Parkinson's.(care... - May 1, 2006 Selegiline safe, effective as adjunct for Parkinson's.(care and treatment)(drug use) ... find Clinical Psychiatry News articles. Pay-Per-View - Clinical Psychiatry News - HighBeam Research Lonnie Ali Champions 'Fight For MORE' Campaign. - Apr 26, 2007 Zelapar is a special formulation of the drug selegiline that adds more active ... Do not take Zelapar if you are allergic to selegiline or any of the other ... $4.95 - PR Newswire - ECNext Business Update; Company submits response to US FDA approvable … - Feb 5, 2005 Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones The selegiline transdermal system (Emsam, Bristol-Myers Squibb/ … - Mar 1, 2006 The selegiline transdermal system (Emsam, Bristol-Myers Squibb/Somerset) was approved for the treatment of major depressive disorder. ... $9.94 - Formulary - Alacra Store FDA DELAYS PDUFA DATE FOR ANTIDEPRESSANT PATCH - Nov 30, 2005 Selegiline products have been linked to hypertensive reactions associated with tyramine, an ingredient contained in several foods, including smoked meats, ... Pay-Per-View - FDAnews Drug Daily Bulletin - Factiva, from Dow Jones … has FDA approval for Zelapar (selegiline HCl) Orally Disintegrating... - Jul 24, 2006 Valeant Pharmaceuticals has FDA approval for Zelapar (selegiline HCl) Orally Disintegrating Tablets. The monoamine oxidase-B inhibitor, using the Zydis oral ... $4.95 - Drug Topics - ECNext … States Code of Federal Regulations - 21 CFR § 520.2098 Selegiline ... - Jul 11, 2006 21 CFR § 520.2098 Selegiline hydrochloride tablets. (a) Specifications. Each tablet contains either 2, 5, 10, 15, or 30 milligrams of selegiline ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw ë°”ë¥¸ì–¸ë¡ ë¹ ë¥¸ë‰´ìŠ¤ ì?¸í„°ë„· 연합뉴스 - Oct 8, 2008 ...ë˜? 서울대병ì›?ì?€ ê°™ì?´ ë³µìš©í• ê²½ìš° 간질ã†?ê³ í˜ˆì•• 등 부작용ì?„ ì?¼ìœ¼í‚¬ ìš°ë ¤ê°€ 있어 병용 처방ì?´ 금지ë?œ `노르트립틸린(nortriptyline)'ê³¼ `ì…€ë ˆê¸¸ë¦°(selegiline)' 성분ì?„ ... 연합뉴스 … has FDA approval for Zelapar (selegiline HCl) Orally Disintegrating... - Jul 24, 2006 Valeant Pharmaceuticals has FDA approval for Zelapar (selegiline HCl) Orally Disintegrating Tablets. Valeant Pharmaceuticals has FDA approval for Zelapar ... $9.94 - Drug Topics - Alacra Store The first transdermal antidepressant.(RX Primer) - Sep 22, 2006 ...(2) In 2006 a transdermal MAOI selegiline patch (EMSAM) was approved by the ... Selegiline (L-Deprenyl) is a selective inhibitor of the MAO-B isoenzyme and ... $4.95 - Annals of the American Psychotherapy... - ECNext Medicine helped senile dog -- can it help humans? - Aug 7, 2005 What can you tell me about selegiline? The vet prescribed it for my elderly dog. ... Our veterinary consultant, Andrea Frost, says that selegiline can be ... Pay-Per-View - The Sun - ProQuest Archiver Selegiline; US FDA approves selegiline transdermal patch for treatment... - Mar 28, 2006 2006 MAR 28 - (NewsRx.com) -- Bristol-Myers Squibb Company (BMY) and Somerset Pharmaceuticals, Inc., a joint venture between Mylan Laboratories Inc. (MYL) ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Evotec Reports Phase I Safety Data From Tyramine Interaction Study... - Oct 27, 2008 At its recommended therapeutic dose selegiline does not require dietary restrictions, ... In this study, the therapeutic dose of selegiline did increase the ... RedOrbit The first transdermal antidepressant.(RX Primer) | Article from... - Sep 22, 2006 ...(2) In 2006 a transdermal MAOI selegiline patch (EMSAM) was approved by the ... Selegiline (L-Deprenyl) is a selective inhibitor of the MAO-B isoenzyme and ... Pay-Per-View - Annals of the American Psychotherapy... - HighBeam Research Management of Parkinson disease: current treatments, recent advances,... - Sep 1, 2007 ...(8) Selegiline monotherapy can be initiated in patients with early-stage PD who ... (12) One study demonstrated that in patients randomized to selegiline, ... $4.95 - Formulary - ECNext selegiline Valeant receives US FDA approval for oral disintegrating... - Jun 26, 2006 ...exhibit deterioration in the quality of their response to this therapy. ....ZELAPAR was developed using Cardinal Health's ZYDIS technology, which allows ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Long-term outcome in Parkinson disease: no advantage to initiating … - Aug 18, 2008 6 The treatment arm that included selegiline was terminated after an interim analysis because of concerns about toxicity. As observed in other trials that ... Nature.com FDA Approvals: Rituxan and Emsam - Mar 3, 2006 On February 27, the FDA approved selegiline transdermal system ( Emsam, ... Patients using the selegiline patch reported sexual dysfunction at a rate ... Medscape Zyvox Oral: Dosage, Uses and Warnings - Aug 10, 2006 4) Entacapone may be used with selegiline, provided that the daily dose of selegiline ... At daily doses of 10 mg, selegiline is primarily a selective MAO-B ... Medscape Send to a friend - Oct 20, 2008 The lead product, Selegiline, is an off-patent monoamine oxidase inhibitor (MAOI) primarily indicated for the treatment of depression, but also with ... Scottish Enterprise Rasagiline preclinical studies: implications for neuroprotection. - Aug 1, 2006 Selegiline (also known as deprenyl) was developed to provide symptomatic benefit ... Early on, however, selegiline was also theorized to have possible ... Free with registration - Formulary - AccessMyLibrary.com Treatment Modalities for Parkinson's Disease - Jun 9, 2008 Selegiline is currently approved for use as adjunctive therapy in ... [11-13] Use of selegiline as monotherapy can also be traced back to data suggesting ... Medscape Article: Orally disintegrating clonazepam.(Brief article) - Clinical ... - Jan 1, 2006 WASHINGTON -- An orally disintegrating formulation of selegiline ... Selegiline taken in the orally disintegrating form significantly decreased ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Can Doggy Drug Ward Off Dementia? - Aug 1, 2005 Q. What can you tell me about selegiline? The vet prescribed it for my elderly ... Several days after she started on selegiline all those behaviors stopped ... HealthCentral.com Rasagiline preclinical studies: implications for neuroprotection. - Aug 1, 2006 Selegiline (also known as deprenyl) was developed to provide symptomatic benefit ... Early on, however, selegiline was also theorized to have possible ... $4.95 - Formulary - ECNext Crunch Time at Teva - Aug 4, 2005 Before patients start using levodopa, physicians prescribe medications including selegiline, which is part of a class of drugs known as selective ... TheStreet.com - TheStreet.com (subscription) Parkinson's patients stomach new drug better than conventional meds - Jun 13, 2006 A new form of the medication selegiline, used for years to manage motor complications ... "This unique formulation of selegiline delivers a more active drug ... News-Medical.net Valeant Pharmaceuticals Announces the Launch of the zelaCARD - Sep 18, 2007 Zelapar is contraindicated in patients with a known hypersensitivity to any formulation of selegiline or any of the inactive ingredients of Zelapar. ... Bloomberg Benefits and Risks of Parkinson's Disease Drugs - Jan 1, 2005 Most of the research (13 studies) evaluated selegiline. Clinical disability ratings were significantly better with use of selegiline in six of the studies. ... AAFP News Now Selegiline G Gam - Indications, Contre indications, Effets indésirable... - Sep 7, 2006 1) En monothérapie : au début de la maladie, la sélégiline permet de différer le recours à la dopathérapie. - au stade des fluctuations de "fin de dose", ... Santé AZ Stanford Study Will Test Antidepressant Patch That May Help Smokers … - Jan 8, 2007 The drug, selegiline, could help smokers combat the cravings they feel when ... Because selegiline is an antidepressant, it could stave off those feelings. ... Free with registration - Business Wire - AccessMyLibrary.com Pharmacology and pharmacokinetics of rasagiline: a selective, … - Aug 1, 2006 Selegiline is derived from an amphetamine pharmacophore and is converted by cytochrome ... Rasagiline and selegiline are both aromatic N-propargylamines, ... $4.95 - Formulary - ECNext 美藥物管ç?†å±€æ ¸å‡†æ–°åž‹æŠ—憂鬱皮膚貼片上市 - Mar 3, 2006 ...電）美國食å“?暨藥物管ç?†å±€ä»Šå¤©æ ¸å‡†èƒ½æ²»ç™‚é‡?度憂鬱症的新型皮膚貼片，患者æ¯?天貼上 這種å??為「Emsamã€?的貼片，便能將Selegiline藥劑é€?é?Žçš®è†šæ»²å…¥è¡€æ¶²ä¸ï¼Œé?”到療效。 ... epochtimes.com FARMACI: USA; VIA LIBERA A CEROTTO CONTRO DEPRESSIONE - Feb 28, 2006 ...alla spina e con altri farmaci: da evitare quando si usa il cerotto a base di selegiline, una sostanza approvata nel 1989 per combattere il Parkinson. ... Regione Basilicata FPIN's Clinical Inquiries - Aug 1, 2005 Treatment of early Parkinson's disease with either selegiline (Eldepryl), ... Comparisons of therapeutic effects of levodopa, levodopa and selegiline, ... AAFP News Now Psychiatric Times. Through the Times With Alan F. Schatzberg, MD - Aug 1, 2005 The second is the selegiline transdermal patch being developed by Somerset Pharmaceuticals ... When you give selegiline transdermally, Schatzberg explained, ... Psychiatric Times Patches and sprays are coming to psychiatry.(Adult Psychiatry) - Jul 1, 2005 Transdermal selegiline may make it possible to achieve the ... Selegiline is an MAO inhibitor prescribed, in its oral formulation, for Parkinson's disease. ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com Article: Emsam, Eraxis.(NEW & APPROVED) - Skin & Allergy News | … - May 1, 2006 NEW & APPROVED) ... find Skin & Allergy News articles. Emsam (selegiline transdermal system, Somerset Pharmaceuticals Inc., Bristol-Myers Squibb) A tr... Pay-Per-View - Skin & Allergy News - HighBeam Research Article: FDA approves Emsam as first drug patch for Depression.(Indust... - May 1, 2006 ...find Pharmaceutical Processing articles. The FDA recently approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major de... Pay-Per-View - Pharmaceutical Processing - HighBeam Research Evotec AG R&D Update Conference Call - Final. - Feb 19, 2007 And selegiline, the older compound, does have a food effect label. ... There has recently been a patch approved for selegiline, which is for use for the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Pharmacotherapy for Parkinson's disease: current options, promising … - Aug 1, 2006 Independent of its MAO-B inhibition, selegiline is believed to protect against ... Selegiline slows the disabling deficits in PD, although its mechanism for ... Free with registration - JAAPA-Journal of the American Academy... - AccessMyLibrary.com Article: Emsam.(Drug Approval ) - Internal Medicine News | HighBeam … - Apr 15, 2006 Drug Approval ) ... find Internal Medicine News articles. Emsam (selegiline transdermal system, Somerset Pharmaceuticals Inc., Bristol-Myers Squibb) ... Pay-Per-View - Internal Medicine News - HighBeam Research Introduction. - Aug 1, 2006 The monoamine oxidase type B (MAO-B) inhibitor selegiline has been shown to ... Unlike selegiline, rasagiline has no intrinsic amphetamine-like effects. ... $4.95 - Formulary - ECNext FDA approves skin patch to treat major depression.(Brief article) |... - May 1, 2006 At its lowest strength (6 milligrams over a 24-hour period), selegiline can be ... For more information about the selegiline patch, visit the FDA Website at ... Pay-Per-View - Journal of Employee Assistance - HighBeam Research FDA panel backs low-dose MAO inhibitor patch.(Rx) | Article from... - Jan 1, 2006 The selegiline patch would be the first transdermal medication approved to ... An oral formulation of selegiline is approved and marketed as Eldepryl for ... Pay-Per-View - Internal Medicine News - HighBeam Research Levodopa medications for Parkinson's disease - Dec 8, 2008 A monoamine oxidase (MAO) inhibitor (such as rasagiline or selegiline), ... Selegiline may be prescribed in some cases, but it is not commonly used. ... WebMD New understanding of the brain helps smokers kick the habit - Mar 18, 2007 The antidepressant patch, called selegiline and marketed under the brand name ... Selegiline has been used for about 20 years to treat Parkinson's disease. ... $2.95 - Oakland Tribune - NewsBank Article: Emsam, Eraxis.(New & Approved) - Family Practice News | … - Apr 15, 2006 New & Approved) ... find Family Practice News articles. Emsam (selegiline transdermal system, Somerset Pharmaceuticals Inc., Bristol-Myers Squibb) A tran... Pay-Per-View - Family Practice News - HighBeam Research FDA Wants Clarity From Valeant - Oct 4, 2005 Zelapar is a faster-acting version of an existing drug, selegiline. Valeant is using a technology that allows the drug to dissolve in seconds and be ... TheStreet.com - TheStreet.com (subscription) Article: New understanding of the brain helps smokers kick the habit ... - Mar 18, 2007 The antidepressant patch, called selegiline and marketed under the brand name ... Selegiline has been used for about 20 years to treat Parkinson's disease. ... Pay-Per-View - Oakland Tribune - HighBeam Research MAO-B inhibitors do not appear to slow Parkinson's disease progression - Aug 25, 2005 I suspect that selegiline delays motor fluctuations as it continuously delivers ... “I would favor selegiline for further study because this is the most ... RxPG NEWS Valeant Pharmaceuticals Announces Availability of Zelapar(R) for … - Jul 18, 2006 Zelapar is contraindicated in patients with a known hypersensitivity to any formulation of selegiline or any of the inactive ingredients of Zelapar. ... Genetic Engineering News - Genetic Engineering News (press release) Four new Parkinson's disease guidelines hailed: review finds insuffici... - Jun 1, 2006 The use of selegiline, levodopa, or a dopamine agonist for the initiation of treatment for PD is supported by the highest level of data. ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com Drugs that improve Parkinson's symptoms may not slow disease … - Aug 29, 2005 ..."I suspect that selegiline delays motor fluctuations as it continuously delivers ... "I would favor selegiline for further study because this is the most ... i-newswire.com Transdermal and intranasal delivery systems now in pipeline for... - Jun 1, 2005 Transdermal selegiline may make it possible to achieve the antidepressant ... Although the MAO inhibitor selegiline is selective at low doses for MAO-B ... Free with registration - Internal Medicine News - AccessMyLibrary.com New practice parameters for Parkinson's hailed.(Disease/Disorder … - Jun 15, 2006 The use of selegiline, levodopa, or a dopamine agonist for the initiation of treatment for PD is supported by the highest level of data. ... Free with registration - Internal Medicine News - AccessMyLibrary.com A Parkinson's disease primer.(CONTINUING EDUCATION: An ongoing … - Oct 22, 2007 Selegiline and rasagiline are both irreversible inhibitors of the enzyme monoamine ... Other results from the trial indicated that selegiline slowed the ... $4.95 - Drug Topics - ECNext Parkinson Disease: New Insights, New Treatment Options. - Oct 1, 2006 Selegiline, available since 1989, has been reformulated in a new ... Selegiline is approved as an adjunct to carbidopa/levodopa for patients who experience ... $4.95 - Consultant - ECNext EBSCOhost Connection: First Depression Patch Approved. - May 1, 2006 Bristol-Myers' skin patch delivers selegiline, a monoamine oxidase inhibitor, through the skin and into the bloodstream. Emsam layers consist of a backing, ... Subscription - FDA Consumer - EBSCO Publishing Article: Zelapar available for PD.(FYI)(Parkinson disease)(Brief... - Nov 1, 2006 ...find Clinical Psychiatry News articles. Zelapar (selegiline HC1, orally disintegrating tablets) is available as an adjunct therapy for Parkinson's pa... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Article: Strategies for innovating new treatments in psychiatry: are... - Nov 1, 2005 Transdermal delivery increases bioavailability of selegiline to the brain, ... At the same time, transdermal delivery of selegiline by passes the gut and ... Pay-Per-View - Psychopharmacology Educational Updates - HighBeam Research Company seeks to expand market for mental health patch as sales … - Apr 13, 2007 Researchers are investigating whether selegiline, the active ingredient in Somerset's Emsam patch, helps people quit smoking. ... Bizjournals.com Why hasn't neuroprotection worked in Parkinson's disease? - Dec 13, 2006 The most notable of these studies have been of selegiline hydrochloride ... (2006) Selegiline slows the progression of the symptoms of Parkinson disease. ... Nature.com More than $126,000 in nationwide settlement with Walgreens announced ... - Jun 4, 2008 20 mg capsules to tablets and Selegiline (generic Eldepryl) from 5 mg tablets to capsules. The switches allegedly occurred from July 2001 through 2005. ... Stamford Plus Magazine FDA approves first patch to treat depression | Article from Chicago... - Mar 1, 2006 The Food and Drug Administration approved the selegiline transdermal patch, ... Selegiline, approved in pill form by the FDA in 1989 to help treat ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Parkinson Disease: Phenomenology and Treatment of the Most Common … - Mar 1, 2008 Antiparkinsonian medications, including selegiline, bromocriptine, pergolide, and pramipexole, are reported to have antidepressant effects. ... Psychiatric Times Article: BMS awards Interlink Emsam interactive work.(contracts of... - May 1, 2006 Emsam (selegiline transdermal system) was developed by Somerset Pharmaceuticals, ... Article: FDA approves emsam (selegiline) as first drug patch for ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research New imaging methods may speed diagnosis of Parkinson's.(Neurology) | ... - May 15, 2005 Article: Selegiline serves as effective adjunct for PD ... ... WASHINGTON -- An orally disintegrating formulation of selegiline appears to be a safe and ... Pay-Per-View - Internal Medicine News - HighBeam Research Adding safinamide to dopamine agonists eases Parkinson's.( … - Aug 1, 2007 Article: Selegiline reduces some adverse events in ... ... The use of selegiline, levodopa, or a dopamine agonist for the initiation of treatment for PD is ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research FDA Panel Recommends No Warning for Low-Dose Emsam - Oct 27, 2005 Currently marketed selegiline products, such as Somerset's Eldepryl, carry warnings about hypertensive reactions associated with tyramine, an ingredient ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones Brand Names/Synonyms: Selegiline is also known by the following brand names and/or synonymsApo-Selegiline; Carbex; Eldepryl; Gen-Selegiline; Jumex; L-Deprenalin; L-E 250; Novo-Selegiline; Nu-Selegiline; Sd Deprenyl; Selegeline Hcl; Selegilina [Inn-Spanish]; Selegiline; Selegiline Hcl; Selegiline-5; Selegilinum [Inn-Latin] Drug Category: Selegiline is categorized under the following by the FDA: Dopaminergics; Neuroprotective Agents; Antiparkinson Agents; Antidyskinetics; Central Nervous System Agents; ATC:N04BD01 Dosage Forms: TABLET Absorption: Rapidly absorbed from the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N-methyl-N-(1-methyl-2-phenyl-ethyl)-prop-2-yn-1-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |